Biobanks Market to Grow Rapidly with Rising Demand for Precision Medicine and Drug Discovery
Biobanks market is driven by the increasing demand for biological sample storage and research activities in genomics, regenerative medicine, and personalized healthcare. The growing use of cryogenic storage systems, freezers, and advanced monitoring systems for preserving human tissues, nucleic acids, and organ samples is significantly supporting market growth. In addition, rising investments in biomedical research, clinical trials, and drug discovery programs are accelerating the adoption of biobanking solutions globally.
Browse the full report description of “Biobanks Market Size, Share & Trends Analysis Report by Equipment (Cryogenic Storage Systems, Refrigerators, Ice Machines, Freezers, Alarm Monitoring Systems, and Others), by Sample Type (Human Fluid, Cell, Human Tissue, and Organ, Nucleic Acids, and Other), and by Application (Therapeutic, Regenerative Medicine, Drug Discovery and Other), Forecast Period (2023-2030)” at https://www.omrglobal.com/industry-reports/biobanks-market
QIAGEN Announced Acquisition of Parse Biosciences to Expand Single-Cell Research Portfolio – 2025
In November 2025, QIAGEN announced the acquisition of Parse Biosciences, a company specializing in scalable single-cell sequencing technologies used in genomics, molecular biology, and biobanking research. The acquisition is expected to strengthen QIAGEN’s sample preparation and life sciences portfolio by enhancing its capabilities in high-throughput biological data generation and analysis. The company stated that integrating Parse Biosciences’ technologies would support growing demand for advanced genomic research, precision medicine, and large-scale biological sample processing within the global biobanks market. The move also aligns with increasing investments in AI-driven healthcare research and next-generation sequencing applications worldwide.
Illumina Announced Acquisition of SomaLogic to Strengthen Multiomics and Proteomics Capabilities – 2025
In June 2025, Illumina entered into a definitive agreement to acquire SomaLogic from Standard BioTools for approximately USD 350 million. The acquisition aims to strengthen Illumina’s multiomics and proteomics capabilities by expanding its portfolio of advanced biomarker discovery and biological sample analysis technologies. Illumina stated that the integration of SomaLogic’s proteomics platform would support precision medicine research, disease profiling, and biobank-driven genomic studies through improved large-scale biological data analysis. The acquisition further enhances Illumina’s strategy to deliver comprehensive omics solutions for healthcare, clinical diagnostics, and life sciences research applications.
QIAGEN Accelerated Investments in Bioinformatics and Digital Insights Platform – 2024
In January 2024, QIAGEN announced expanded investments in QIAGEN Digital Insights (QDI), its bioinformatics and molecular data interpretation business focused on omics analysis and precision medicine applications. The investment is intended to improve AI-enabled biological data management, genomic interpretation workflows, and digital research capabilities supporting the increasing digitization of biobanks and genomic repositories. QIAGEN stated that strengthening its bioinformatics infrastructure would help researchers and healthcare organizations manage large-scale molecular datasets more efficiently while supporting advancements in personalized medicine, translational research, and next-generation genomic analysis technologies.
About OMR Global
OMR Global is a market intelligence and strategic consulting firm specializing in growth advisory, competitive intelligence, and AI-enabled business research across global B2B industries.
The company supports enterprises, investors, and technology providers with actionable insights for market entry, investment analysis, procurement strategy, commercialization, and business expansion. OMR Global combines industry expertise, primary research, analytics, and digital intelligence tools to help organizations navigate evolving market landscapes and identify growth opportunities.
OMR Digital Offerings
- Pulse Intelligence Platform – AI-powered market intelligence suite designed to deliver analyst-grade insights faster and more efficiently. Built on 12+ years of research expertise and enhanced with AI-driven analytics, Pulse helps organizations transform large volumes of market and company data into actionable intelligence within hours instead of weeks. Trusted by Fortune 500 enterprises, global investment banks, strategy consultancies, and PE & VC firms, Pulse supports strategic decision-making across investment evaluation, competitive benchmarking, AI readiness, and market positioning.
Other Offerings
- Lead Generation – Verified B2B prospect data, ICP targeting, and intent-based sales intelligence
- RFx Support – End-to-end RFP, RFI, and RFQ support with vendor benchmarking and evaluation frameworks
OMR Global delivers data-driven intelligence solutions designed to support strategic decision-making, operational efficiency, and long-term business growth.
To find out more, visit www.omrglobal.com
Contact:
Mr. Anurag Tiwari
305-308, Commerce House, Janjeerwala Square,
Indore, Madhya Pradesh 452001
India
+91-780-304-0404